{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:29Z","timestamp":1790899469302,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.ejca.2005.03.023","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T11:25:42Z","timestamp":1118748342000},"page":"1628-1636","source":"Crossref","is-referenced-by-count":82,"title":["Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: The role of promoter methylation of TSC genes"],"prefix":"10.1016","volume":"41","author":[{"given":"Wen G.","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lee-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Douglas-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefah","family":"Mokbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Mansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2005.03.023_bib1","doi-asserted-by":"crossref","unstructured":"The European chromosome 16 tuberous sclerosis consortium, Identification and characterisation of the tuberous sclearosis gene on chromosome. Cell 1993, 16, 1305\u201315.","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"10.1016\/j.ejca.2005.03.023_bib2","doi-asserted-by":"crossref","unstructured":"The TSC1 Consortium. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science, 277, 1997, 805\u20138.","DOI":"10.1126\/science.277.5327.805"},{"key":"10.1016\/j.ejca.2005.03.023_bib3","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.03.023_bib4","first-page":"400","article-title":"Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions","volume":"59","author":"Henske","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejca.2005.03.023_bib5","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1074\/jbc.272.10.6097","article-title":"The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis","volume":"272","author":"Xiao","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.03.023_bib6","first-page":"1206","article-title":"Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice","volume":"59","author":"Kobayashi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.03.023_bib7","doi-asserted-by":"crossref","first-page":"15629","DOI":"10.1073\/pnas.95.26.15629","article-title":"Loss of function of the tuberous sclerosis 2 tumour suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development","volume":"95","author":"Rennebeck","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.03.023_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"TSC2+\/\u2212 mice develop tumours in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejca.2005.03.023_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63840-0","article-title":"Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumour suppressor gene during development","volume":"162","author":"Cai","year":"2003","journal-title":"Am J Pathology"},{"key":"10.1016\/j.ejca.2005.03.023_bib10","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/hmg\/11.24.2997","article-title":"Identification of the coding sequences responsible for Tsc2-mediated tumour suppression using a transgenic rat system","volume":"11","author":"Momose","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejca.2005.03.023_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/carcin\/24.3.573","article-title":"Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat","volume":"24","author":"Habib","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejca.2005.03.023_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ana.410420215","article-title":"Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas","volume":"42","author":"Wienecke","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejca.2005.03.023_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/hmg\/7.6.1053","article-title":"Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products","volume":"7","author":"van Slegtenhorst","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejca.2005.03.023_bib14","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/hmg\/10.25.2899","article-title":"Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin","volume":"10","author":"Hodges","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejca.2005.03.023_bib15","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"Benvenuto","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2005.03.023_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ncb847","article-title":"Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling","volume":"4","author":"Gao","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ejca.2005.03.023_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inocki","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ejca.2005.03.023_bib18","doi-asserted-by":"crossref","first-page":"29301","DOI":"10.1074\/jbc.272.46.29301","article-title":"Role of the tuberous sclerosis gene-2 product in cell cycle control \u2013 loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase","volume":"272","author":"Soucek","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.03.023_bib19","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/hmg\/9.12.1721","article-title":"The TSC1 gene product, hamartin, negatively regulates cell proliferation","volume":"9","author":"Miloloza","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejca.2005.03.023_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/35010550","article-title":"The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho","volume":"2","author":"Lamp","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ejca.2005.03.023_bib21","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/sj.onc.1205962","article-title":"Tuberin, the tuberous sclerosis complex 2 tumour suppressor gene product, regulates Rho activation, cell adhesion and migration","volume":"21","author":"Astrinidis","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2005.03.023_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mc.10034","article-title":"Retention of membrane-localized beta-catenin in cells lacking functional polycystin-1 and tuberin","volume":"33","author":"Kugoh","year":"2002","journal-title":"Mol Carcinogen"},{"key":"10.1016\/j.ejca.2005.03.023_bib23","first-page":"6432","article-title":"Retroviral hammerhead transgenes to cMET and HGF\/SF inhibited growth of breast tumour, induced by fibroblasts","volume":"9","author":"Jiang","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2005.03.023_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ijc.11302","article-title":"Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer","volume":"106","author":"Jiang","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2005.03.023_bib25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1677\/erc.1.00825","article-title":"Contrasting role of Cyr61 from CTGF and Nov in human breast cancer","volume":"11","author":"Jiang","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejca.2005.03.023_bib26","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.03.023_bib27","doi-asserted-by":"crossref","first-page":"48707","DOI":"10.1074\/jbc.M405528200","article-title":"Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2","volume":"279","author":"Rosner","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.03.023_bib28","doi-asserted-by":"crossref","first-page":"25605","DOI":"10.1074\/jbc.M402790200","article-title":"Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumour suppressor pathways","volume":"279","author":"Birchenall-Roberts","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.03.023_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumour suppressor negatively regulates mTOR signaling","volume":"6","author":"Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2005.03.023_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumour suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ejca.2005.03.023_bib31","first-page":"3469","article-title":"Tuberous sclerosis-associated neoplasms express activated p42\/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumour growth","volume":"9","author":"Govindarajan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2005.03.023_bib32","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1158\/0008-5472.CAN-03-3609","article-title":"Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment","volume":"64","author":"El-Hashemite","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.03.023_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1034\/j.1600-0560.2001.028009470.x","article-title":"Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis","volume":"28","author":"Nguyen-Vu","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2005.03.023_bib34","first-page":"5173","article-title":"Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin","volume":"63","author":"El-Hashemite","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.03.023_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2005.03.023_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jnci\/89.2.139","article-title":"Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma","volume":"89","author":"Gasparini","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2005.03.023_bib37","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.2000.18.7.1423","article-title":"Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment","volume":"18","author":"Linderholm","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.03.023_bib38","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1158\/1078-0432.CCR-03-0115","article-title":"Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer","volume":"10","author":"Wulfing","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2005.03.023_bib39","doi-asserted-by":"crossref","first-page":"23114","DOI":"10.1074\/jbc.M401912200","article-title":"Estrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of platelet-derived growth factor receptor-beta and ERK-1\/2","volume":"279","author":"Finlay","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.03.023_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201276","article-title":"Distinct effects of single amino-acid changes to tuberin on the function of the tuberin\u2013hamartin complex","volume":"13","author":"Nellist","year":"2005","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905003266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905003266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T18:36:44Z","timestamp":1586284604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804905003266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0959804905003266"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2005.03.023","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}